United States: New CMS Most Favored Nation Drug Pricing Rule Could Negatively Impact The Bottom Lines Of Hospitals, Physician Practices - Hall, Render, Killian, Health & Lyman

United States: New CMS Most Favored Nation Drug Pricing Rule Could Negatively Impact The Bottom Lines Of Hospitals, Physician Practices - Hall, Render, Killian, Health & Lyman

Mondaq

Published

The Centers for Medicare & Medicaid Services ("CMS") published an Interim Final Rule on November 27, 2020 that creates a new drug reimbursement model tying Medicare Part B drug reimbursement...

Full Article